Vimarsana
Biggest News Aggregation in the World

Page 3 - Michaela Carr News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Michaela Carr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Michaela Carr Today - Breaking & Trending Today

Calyxt, Inc. (CLXT) Q3 2022 Earnings Call Transcript - Vimarsana News

Calyxt, Inc. (CLXT) Q3 2022 Earnings Call Transcript

Calyxt, Inc. (NASDAQ:NASDAQ:CLXT) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants William Koschak - CFO Michael Carr - President and CEO Presentation...

Calyxt Reports Third Quarter 2022 Financial Results and Provides Corporate Update - Vimarsana News

Calyxt Reports Third Quarter 2022 Financial Results and Provides Corporate Update

—Successfully produced squalene, an important ingredient for personal care products and vaccine adjuvants— —Continued to progress customer acquisition...

Calyxt Successfully Produces Plant-Based Squalene, an Important Ingredient in Personal Care Products and Critical Vaccine Adjuvants - Vimarsana News

Calyxt Successfully Produces Plant-Based Squalene, an Important Ingredient in Personal Care Products and Critical Vaccine Adjuvants

/PRNewswire/ -- Calyxt, Inc. (NASDAQ: CLXT), a plant-based synthetic biology company, announced today that using a Calyxt-engineered Plant Cell Matrix™...

Calyxt, Evologic Technologies to Scale Up Sustainable Plant-based Ingredients - Vimarsana News

Calyxt, Evologic Technologies to Scale Up Sustainable Plant-based Ingredients

The agreement aims to power a speed-to-scale strategy to meet growing interest in high-quality sustainable ingredients across the cosmeceutical, nutraceutical and pharmaceutical markets.

Calyxt Announces Agreement with Evologic Technologies to Scale Production of its Plant-based Ingredients - Vimarsana News

Calyxt Announces Agreement with Evologic Technologies to Scale Production of its Plant-based Ingredients

/PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced that it has signed an agreement with its first...